P. Sanz-Cameno

1.1k total citations
29 papers, 764 citations indexed

About

P. Sanz-Cameno is a scholar working on Hepatology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Sanz-Cameno has authored 29 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 17 papers in Epidemiology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Sanz-Cameno's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (13 papers) and Lipid metabolism and disorders (7 papers). P. Sanz-Cameno is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (13 papers) and Lipid metabolism and disorders (7 papers). P. Sanz-Cameno collaborates with scholars based in Spain, United States and Netherlands. P. Sanz-Cameno's co-authors include Ricardo Moreno‐Otero, Samuel Martín‐Vílchez, Luisa Garcı́a-Buey, Manuel López‐Cabrera, M.J. Borque, María Trapero-Marugán, Enrique Lara‐Pezzi, J. Medina, María Chaparro and Francisca Molina‐Jiménez and has published in prestigious journals such as PLoS ONE, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

P. Sanz-Cameno

29 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Sanz-Cameno Spain 15 455 411 170 114 94 29 764
Manabu Daikoku Japan 17 686 1.5× 777 1.9× 127 0.7× 108 0.9× 117 1.2× 28 1.1k
Nobuyuki Torii Japan 18 597 1.3× 868 2.1× 173 1.0× 43 0.4× 81 0.9× 48 1.1k
Masao Omata Japan 16 376 0.8× 430 1.0× 72 0.4× 65 0.6× 117 1.2× 24 721
Vanessa Teaberry United States 8 273 0.6× 486 1.2× 317 1.9× 190 1.7× 83 0.9× 8 893
Po–Sung Chu Japan 15 343 0.8× 442 1.1× 154 0.9× 242 2.1× 75 0.8× 42 825
Brian B. Borg United States 14 519 1.1× 847 2.1× 179 1.1× 75 0.7× 210 2.2× 31 1.2k
Yoshifumi Fujimoto Japan 20 422 0.9× 733 1.8× 184 1.1× 73 0.6× 194 2.1× 44 1.2k
Sílvia Vilarinho United States 18 292 0.6× 446 1.1× 163 1.0× 168 1.5× 129 1.4× 37 896
Seiji Miyazoe Japan 9 394 0.9× 500 1.2× 156 0.9× 129 1.1× 106 1.1× 10 726
Catherine Edwards-Smith Australia 7 422 0.9× 391 1.0× 83 0.5× 284 2.5× 63 0.7× 10 832

Countries citing papers authored by P. Sanz-Cameno

Since Specialization
Citations

This map shows the geographic impact of P. Sanz-Cameno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Sanz-Cameno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Sanz-Cameno more than expected).

Fields of papers citing papers by P. Sanz-Cameno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Sanz-Cameno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Sanz-Cameno. The network helps show where P. Sanz-Cameno may publish in the future.

Co-authorship network of co-authors of P. Sanz-Cameno

This figure shows the co-authorship network connecting the top 25 collaborators of P. Sanz-Cameno. A scholar is included among the top collaborators of P. Sanz-Cameno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Sanz-Cameno. P. Sanz-Cameno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vidal-Castiñeira, José Ramón, Antonio López‐Vázquez, Leonardo Márquez‐Kisinousky, et al.. (2020). Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection. Journal of Molecular Medicine. 98(9). 1245–1254. 1 indexed citations
2.
López‐Rodríguez, Rosario, M.J. Borque, Samuel Martín‐Vílchez, et al.. (2017). Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C. PLoS ONE. 12(7). e0180927–e0180927. 7 indexed citations
3.
López‐Rodríguez, Rosario, et al.. (2016). Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. World Journal of Gastroenterology. 22(44). 9744–9744. 14 indexed citations
4.
Martín‐Vílchez, Samuel, Rosario López‐Rodríguez, Francisca Molina‐Jiménez, et al.. (2014). Inhibition of Tyrosine Kinase Receptor Tie2 Reverts HCV-Induced Hepatic Stellate Cell Activation. PLoS ONE. 9(10). e106958–e106958. 4 indexed citations
5.
Vidal-Castiñeira, José Ramón, Antonio López‐Vázquez, Jesús Martı́nez-Borra, et al.. (2014). Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome. PLoS ONE. 9(6). e99426–e99426. 13 indexed citations
6.
López‐Rodríguez, Rosario, Samuel Martín‐Vílchez, M.J. Borque, et al.. (2013). Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link. PLoS ONE. 8(6). e66143–e66143. 12 indexed citations
7.
López‐Rodríguez, Rosario, M.J. Borque, Samuel Martín‐Vílchez, et al.. (2013). Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy. Genes and Immunity. 14(5). 317–324. 9 indexed citations
8.
Vidal-Castiñeira, José Ramón, Antonio López‐Vázquez, Rebeca Alonso‐Arias, et al.. (2012). A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping. Journal of Hepatology. 56(6). 1230–1238. 17 indexed citations
9.
Martín‐Vílchez, Samuel, Ricardo Moreno‐Otero, & P. Sanz-Cameno. (2012). Mecanismos de acción y efectos de la proteína X (HBx) en la patogenia de la hepatitis crónica B. Medicina Clínica. 140(11). 508–513. 2 indexed citations
10.
Rueda, Paloma Muñoz de, Miguel Ángel López‐Nevot, Pablo Sáenz-López, et al.. (2011). Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin. The American Journal of Gastroenterology. 106(7). 1246–1254. 30 indexed citations
11.
López‐Rodríguez, Rosario, María Trapero-Marugán, M.J. Borque, et al.. (2011). Genetic Variants of Interferon-Stimulated Genes and IL-28B as Host Prognostic Factors of Response to Combination Treatment for Chronic Hepatitis C. Clinical Pharmacology & Therapeutics. 90(5). 712–721. 18 indexed citations
12.
Sanz-Cameno, P., et al.. (2010). Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma. Journal of Oncology. 2010. 1–7. 58 indexed citations
13.
Figueroa‐Vega, Nicté, P. Sanz-Cameno, Ricardo Moreno‐Otero, et al.. (2009). Serum Levels of Angiogenic Molecules in Autoimmune Thyroid Diseases and Their Correlation with Laboratory and Clinical Features. The Journal of Clinical Endocrinology & Metabolism. 94(4). 1145–1153. 32 indexed citations
14.
Martín‐Vílchez, Samuel, P. Sanz-Cameno, Pedro Majano, et al.. (2008). The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology. 47(6). 1872–1883. 89 indexed citations
15.
Martín‐Vílchez, Samuel, Francisca Molina‐Jiménez, José L. Alonso-Lebrero, et al.. (2008). AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cells. British Journal of Pharmacology. 154(3). 698–708. 12 indexed citations
16.
Sanz-Cameno, P., Samuel Martín‐Vílchez, Enrique Lara‐Pezzi, et al.. (2006). Hepatitis B Virus Promotes Angiopoietin-2 Expression in Liver Tissue. American Journal Of Pathology. 169(4). 1215–1222. 59 indexed citations
17.
Sanz-Cameno, P., J. Medina, Samuel Martín‐Vílchez, et al.. (2005). Association between angiogenesis soluble factors and disease progression markers in chronic hepatitis C patients. Revista Española de Enfermedades Digestivas. 97(10). 699–706. 19 indexed citations
18.
Medina, J., P. Sanz-Cameno, Luisa Garcı́a-Buey, et al.. (2005). The Potential of Angiogenesis Soluble Markers in Chronic Hepatitis C *. Hepatology. 42(3). 696–701. 60 indexed citations
19.
Medina, J., et al.. (2005). Review article: angiogenesis soluble factors as liver disease markers. Alimentary Pharmacology & Therapeutics. 22(1). 23–30. 31 indexed citations
20.
Sanz-Cameno, P., Jesús Medina, Luisa Garcı́a-Buey, et al.. (2002). Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. Journal of Hepatology. 37(6). 723–729. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manabu Daikoku Breakdown of academic impact, for papers by Nobuyuki Torii Breakdown of academic impact, for papers by Masao Omata Breakdown of academic impact, for papers by Vanessa Teaberry Breakdown of academic impact, for papers by Po–Sung Chu Breakdown of academic impact, for papers by Brian B. Borg Breakdown of academic impact, for papers by Yoshifumi Fujimoto Breakdown of academic impact, for papers by Sílvia Vilarinho Breakdown of academic impact, for papers by Seiji Miyazoe Breakdown of academic impact, for papers by Catherine Edwards-Smith
Rankless by CCL
2026